Vigabatrin for infantile spasms.

Abstract:

:Infantile spasms describe a pediatric epilepsy syndrome characterized by frequent clusters of brief symmetric muscle contractions; the condition is often associated with developmental delay. When infantile spasms are accompanied by hypsarrhythmia on electroencephalogram, the condition is labeled West syndrome. The mainstay of treatment for infantile spasms is adrenocorticotropic hormone; however, vigabatrin, a vinyl derivative of γ-aminobutyric acid, has been used for the treatment of infantile spasms in Europe since 1989. In 2009, vigabatrin was approved by the United States Food and Drug Adminstration (FDA) for use as monotherapy in the treatment of infantile spasms in patients aged 1 month-2 years when the benefits of treatment outweigh the risks. Results from numerous trials examining the role of vigabatrin in infantile spasms have been published; many of these trials were small, open-label, or noncontrolled. Although clinical trials have provided some insight into the utility of vigabatrin for the treatment of infantile spasms, these studies have notable limitations. In addition, vigabatrin is associated with a black-box warning that describes the potential for permanent bilateral concentric visual field defects. Currently, vigabatrin is available through a manufacturer-sponsored program in accordance with its FDA-approved Risk Evaluation and Mitigation Strategy. Although several guidelines recommend vigabatrin as a first-line therapy for infantile spasms, specifically infantile spasms related to tuberous sclerosis, it is still unclear whether vigabatrin should supersede hormone therapy as first-line therapy. Further research comparing the two therapies is needed.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Pesaturo KA,Spooner LM,Belliveau P

doi

10.1592/phco.31.3.298

subject

Has Abstract

pub_date

2011-03-01 00:00:00

pages

298-311

issue

3

eissn

0277-0008

issn

1875-9114

pii

10.1592/phco.31.3.298

journal_volume

31

pub_type

杂志文章,评审
  • Dosage forms of cyclosporine.

    abstract::Cyclosporine can be given intravenously or orally, as a solution or soft gelatin capsule. Because of the drug's poor water solubility, ethoxylated plant fats and ethanol are added to the commercially available dosage forms. ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Yee GC

    更新日期:1991-01-01 00:00:00

  • Prepharmacy predictors of success in pharmacy school: grade point averages, pharmacy college admissions test, communication abilities, and critical thinking skills.

    abstract::Good admissions decisions are essential for identifying successful students and good practitioners. Various parameters have been shown to have predictive power for academic success. Previous academic performance, the Pharmacy College Admissions Test (PCAT), and specific prepharmacy courses have been suggested as acade...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.9.842.34566

    authors: Allen DD,Bond CA

    更新日期:2001-07-01 00:00:00

  • Comparison of prescription drug costs in the United States and the United Kingdom, part 2: proton pump inhibitors.

    abstract:STUDY OBJECTIVE:To compare the annual cost of proton pump inhibitors (PPIs) in the United States and in the United Kingdom. DESIGN:Matched-cohort cost analysis. DATA SOURCES:U.K. General Practice Research Database (GPRD) and MarketScan Commercial Claims and Encounter Database, a large, U.S. self-insured medical claim...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/j.1875-9114.2012.01111.x

    authors: Jick H,Wilson A,Wiggins P,Chamberlain DP

    更新日期:2012-06-01 00:00:00

  • Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice.

    abstract::Antiretroviral (ART) therapy for the treatment of human immunodeficiency virus (HIV) infection has undergone significant changes over the past 30 years. Many single-tablet regimens (STRs), including newer fixed-dose combination (FDC) tablets, are available, offering patients several options for choosing a treatment re...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2055

    authors: McCoy C,Badowski M,Sherman E,Crutchley R,Smith E,Chastain DB,Society of Infectious Diseases Pharmacists.

    更新日期:2018-01-01 00:00:00

  • Monoclonal antibodies in the treatment of steroid-resistant acute graft-versus-host disease.

    abstract::Acute graft-versus-host disease (GVHD) remains the major obstacle for successful allogeneic bone marrow transplantation (BMT). The frequency of grade II or higher acute GVHD ranges from 30-50% in human leukocyte antigen (HLA)-matched sibling transplants and 50-80% in HLA-matched unrelated transplants. The mortality an...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Tse JC,Moore TB

    更新日期:1998-09-01 00:00:00

  • Evaluation of the half-life of intravenous human cytomegalovirus immune globulin in patients receiving partially mismatched related donor bone marrow transplantation.

    abstract:STUDY OBJECTIVE:To evaluate the pharmacokinetics and use of intravenous human cytomegalovirus immune globulin (CytoGam) in allogeneic bone marrow transplantation (BMT). DESIGN:Prospective, nonrandomized, nonblinded, single-center study. SETTING:University teaching hospital. PATIENTS:Five consecutive patients with he...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.15.1175.34592

    authors: DeRienzo SY,Chiang KY,O'Neal WM,Godder K,Abhyankar S,Christiansen NP,Bridges KD,Henslee-Downey PJ

    更新日期:2000-10-01 00:00:00

  • Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory.

    abstract::One of the initial steps for implementing pharmacogenomics into routine patient care is selecting an appropriate clinical laboratory to perform the testing. With the rapid advances in genotyping technologies, many clinical laboratories are now performing pharmacogenomic testing. Selection of a reference laboratory dep...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1985

    authors: Vo TT,Bell GC,Owusu Obeng A,Hicks JK,Dunnenberger HM

    更新日期:2017-09-01 00:00:00

  • Ceftaroline-induced eosinophilic pneumonia.

    abstract::We present a case of eosinophilic pneumonia due to ceftaroline used for the treatment of methicillin-resistant Staphylococcus aureus bacteremia associated with a postoperative spinal infection. Our patient developed shortness of breath and hypoxemia on the fifth week of ceftaroline therapy. Chest imaging disclosed dif...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1286

    authors: Desai KR,Burdette SD,Polenakovik HM,Hagaman J,Pleiman CM

    更新日期:2013-07-01 00:00:00

  • Recommendations for generating, evaluating, and implementing drug-drug interaction evidence.

    abstract::In October 2009, a 2-day, multistakeholder, national conference was held in Rockville, Maryland, to discuss and propose methods to improve the drug-drug interaction (DDI) evidence base and its evaluation and integration into clinical decision support (CDS) systems. The conference featured participants representing con...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/j.1875-9114.2012.01024.x

    authors: Hines LE,Malone DC,Murphy JE

    更新日期:2012-04-01 00:00:00

  • Discrepancies in identification of major bleeding events in patients taking warfarin.

    abstract:STUDY OBJECTIVE:To assess the level of agreement between one subjective definition of major bleeding (criteria A) and two objective definitions: the International Society on Thrombosis and Haemostasis ([ISTH] criteria B) and the Italian Study of Complications of Anticoagulant Therapy ([ISCOAT] criteria C). DESIGN:Retr...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.9.1098

    authors: Seto AC,Kenyon K,Wittkowsky AK

    更新日期:2008-09-01 00:00:00

  • Treatment of supraventricular tachyarrhythmias with intravenous calcium channel blockers: are subtle differences worth the cost?

    abstract::Verapamil and diltiazem are effective in terminating paroxysmal supraventricular tachycardias and slowing ventricular response during atrial fibrillation or flutter. Results from clinical trials for each individual drug demonstrate comparative efficacy rates, and both drugs share the same contraindications and relativ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Cheiman DM,Shea BF,Kelly RA

    更新日期:1996-09-01 00:00:00

  • Economic analysis of alvimopan for prevention and management of postoperative ileus.

    abstract:STUDY OBJECTIVE:To determine whether alvimopan for prevention of postoperative ileus in patients undergoing small- or large-bowel resection by laparotomy is associated with lower total costs compared with standard care. DESIGN:Pharmacoeconomic analysis using a formal decision model. DATA SOURCE:Four phase III clinica...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/PHAR.1047

    authors: Touchette DR,Yang Y,Tiryaki F,Galanter WL

    更新日期:2012-02-01 00:00:00

  • Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.

    abstract::Neuroleptic malignant syndrome (NMS) is an idiosyncratic and uncommon but serious adverse effect that has been reported with both typical and atypical antipsychotic agents. We describe a 58-year-old man with Down syndrome and dementia who was receiving low-dose olanzapine and rivastigmine therapy; he developed NMS 4 m...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.3.403

    authors: Stevens DL,Lee MR,Padua Y

    更新日期:2008-03-01 00:00:00

  • Low-dosage methotrexate for treatment and maintenance of remission in patients with inflammatory bowel disease.

    abstract::A literature search was conducted to examine the safety and effectiveness of low-dosage methotrexate for treatment and maintenance of remission in patients with inflammatory bowel disease. Nine published articles indicated that for patients with Crohn's disease, oral or intramuscular methotrexate 20-25 mg/week is safe...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.22.8.613.33208

    authors: Vandell AG,DiPiro JT

    更新日期:2002-05-01 00:00:00

  • Key articles and guidelines for the prevention of venous thromboembolism.

    abstract::Venous thromboembolism (VTE) is an important medical problem that affects millions of patients each year. With appropriate prophylaxis, many of these thromboembolic events can be prevented. Although strong evidence supporting VTE prophylaxis spans several decades, several large American and global registries have docu...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1592/phco.29.4.410

    authors: Dobesh PP,Wittkowsky AK,Stacy Z,Dager WE,Haines ST,Lopez LM,Nutescu E,Phillips KW,Trujillo TC,Vondracek T

    更新日期:2009-04-01 00:00:00

  • Comparison of neural network, Bayesian, and multiple stepwise regression-based limited sampling models to estimate area under the curve.

    abstract::This study compared limited sampling methods (LSM) of estimating area under the plasma concentration versus time curve (AUC) based on a Bayesian regularized neural network, the Bayesian approach, and multiple forward stepwise regression models from selected concentration-time points. Plasma concentration versus time d...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.23.8.1044.32872

    authors: Ng CM

    更新日期:2003-08-01 00:00:00

  • Quinupristin-dalfopristin: an overview.

    abstract::Synercid (RP 59500), the first injectable streptogramin antibiotic, is composed of two semisynthetic pristinamycin derivatives, quinupristin and dalfopristin. Individually, each component has bacteriostatic activity against staphylococci and streptococci, but together, the agents exhibit synergy, leading to bactericid...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.20.19.1469.34858

    authors: Delgado G Jr,Neuhauser MM,Bearden DT,Danziger LH

    更新日期:2000-12-01 00:00:00

  • Telavancin: an antimicrobial with a multifunctional mechanism of action for the treatment of serious gram-positive infections.

    abstract::Telavancin is a once-daily lipoglycopeptide antibiotic structurally derived from vancomycin. It has broad-spectrum activity against gram-positive bacteria, including strains with reduced susceptibility to vancomycin. Telavancin's multifunctional mechanism of action, including inhibition of peptidoglycan synthesis and ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.28.4.458

    authors: Leonard SN,Rybak MJ

    更新日期:2008-04-01 00:00:00

  • Octreotide-Associated Neutropenia.

    abstract::Drug-induced neutropenia and agranulocytosis are rare adverse events but can be fatal. Neutropenia can be induced by a myriad of drugs from almost every pharmacologic class. Octreotide is a somatostatin analog that has been used to treat variceal bleeding, acromegaly, and severe diarrhea associated with metastatic tum...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1002/phar.1942

    authors: Tse SS,Kish T

    更新日期:2017-06-01 00:00:00

  • Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.

    abstract:STUDY OBJECTIVE:To assess the influence of withholding continuous enteral nutrition for 1 hour before and after warfarin administration compared with the coadministration of warfarin with continuous enteral nutrition on changes in international normalized ratios (INRs). DESIGN:Retrospective, crossover case series. SE...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.3.308

    authors: Dickerson RN,Garmon WM,Kuhl DA,Minard G,Brown RO

    更新日期:2008-03-01 00:00:00

  • Pharmacists' assessment of dispensing errors: risk factors, practice sites, professional functions, and satisfaction.

    abstract::Certain demographic, practice, staffing, and pharmacist satisfaction variables may contribute to dispensing errors. A survey was randomly mailed to 7298 (50%) Texas pharmacists, of which 2862 were returned (39% response rate). Responders were 2437 pharmacists who indicated that they were in practice. Of these, 535 (23...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.21.6.614.34544

    authors: Bond CA,Raehl CL

    更新日期:2001-05-01 00:00:00

  • Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients.

    abstract:STUDY OBJECTIVE:To characterize a time-dependent disposition of oral tacrolimus and its relationship with plasma endothelin-1 concentrations. DESIGN:Randomized, crossover study. SETTING:Clinical research center of a university-affiliated hospital. PATIENTS:Twelve stable liver transplant recipients. INTERVENTIONS:In...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Min DI,Chen HY,Lee MK,Ashton K,Martin MF

    更新日期:1997-05-01 00:00:00

  • Advances in the treatment and prophylaxis of Pneumocystis carinii pneumonia.

    abstract::Pneumocystis carinii pneumonia (PCP) is the most common illness associated with the acquired immunodeficiency syndrome (AIDS) in the United States and also occurs in immunocompromised persons not infected with the human immunodeficiency virus.. Several advances have taken place in the treatment and prophylaxis of PCP,...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Warren E,George S,You J,Kazanjian P

    更新日期:1997-09-01 00:00:00

  • Clinical Outcomes with Penicillin Versus Alternative β-Lactams in the Treatment of Penicillin-Susceptible Staphylococcus aureus Bacteremia.

    abstract:OBJECTIVES:To identify the impact of penicillin versus alternative β-lactams on clinical outcomes in patients with penicillin-susceptible Staphylococcus aureus (PSSA) bacteremia. DESIGN:Retrospective cohort study. SETTING:Academic medical center. PATIENTS:Adult patients with PSSA bacteremia treated with a β-lactam a...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2124

    authors: Shah MD,Wardlow LC,Stevenson KB,Coe KE,Reed EE

    更新日期:2018-07-01 00:00:00

  • Issues in developing an outpatient deep venous thrombosis treatment program: university hospital experience.

    abstract::Low-molecular-weight heparins (LMWHs) are safe and effective in the treatment of venous thromboembolic disease. Since they require less therapeutic monitoring than unfractionated heparin and may be administered to outpatients, it is possible to decrease overall health care costs of patients diagnosed with deep vein th...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Yurkowski P

    更新日期:1998-11-01 00:00:00

  • Treatment options for nausea and vomiting during pregnancy.

    abstract::Nausea and vomiting, common symptoms during pregnancy, often are regarded as an unpleasant but normal part of pregnancy during the first and early second trimesters. Nausea and vomiting of pregnancy (NVP) occurs in approximately 75-80% of pregnant women. The exact etiology and pathogenesis of NVP are poorly understood...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.26.9.1273

    authors: Badell ML,Ramin SM,Smith JA

    更新日期:2006-09-01 00:00:00

  • Case-control study of amphotericin B in a triglyceride fat emulsion versus conventional amphotericin B in patients with AIDS.

    abstract::We evaluated the efficacy and tolerability of amphotericin B triglyceride emulsion in 16 patients with acquired immunodeficiency syndrome-related candidal esophagitis and cryptococcosis, compared with standard amphotericin B in 24 patients. Compared with the conventional formulation, the fat emulsion was administered ...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:

    authors: Manfredi R,Chiodo F

    更新日期:1998-09-01 00:00:00

  • Propofol-related infusion syndrome in intensive care patients.

    abstract::The Institute of Medicine has identified adverse drug events as factors that significantly contribute to increased patient morbidity and mortality. As critically ill patients receive numerous drugs to treat a multitude of complicated health problems, they are at high risk for adverse drug events. Sedation is often a k...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.28.2.250

    authors: Corbett SM,Montoya ID,Moore FA

    更新日期:2008-02-01 00:00:00

  • A case report of warfarin resistance due to azathioprine and review of the literature.

    abstract::A 32-year-old woman with a history of deep vein thrombosis (DVT), steroid-dependent ulcerative colitis, and osteoporosis was prescribed azathioprine for a steroid-sparing effect. Stable, therapeutic international normalized ratios (INRs) were obtained with warfarin 35 mg/week during a 6-week postpartum course to treat...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.3.355.34208

    authors: Havrda DE,Rathbun S,Scheid D

    更新日期:2001-03-01 00:00:00

  • Recurrent peripheral arterial thrombosis induced by cisplatin and etoposide.

    abstract::A 64-year-old woman receiving intravenous chemotherapy for stage IIIB non-small cell lung cancer experienced acute arterial thrombosis of the distal radial and entire ulnar arteries with subsequent arterial occlusion of the right popliteal artery. Two separate arterial occlusions occurred after administration of cispl...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.22.13.1200.33524

    authors: Cool RM,Herrington JD,Wong L

    更新日期:2002-09-01 00:00:00